1-20 of 20
Robert Peter Gale
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clonal Megakaryocyte Dysplasia with Isolated Thrombocytosis Is a Distinct Myeloproliferative Neoplasm Phenotype

Subject Area:
Karger e-Journal Backfile Collection 2023 , Hematology , Oncology
Giovanni Barosi, Rita Campanelli, Margherita Massa, Paolo Catarsi, Adriana Carolei, Carlotta Abbà, Laura Villani, Umberto Magrini, Giuliana Gregato, Francesco Bertolini, Annalisa de Silvestri, Robert Peter Gale, Vittorio Rosti
Journal: Acta Haematologica
Acta Haematol (2023) 146 (1): 15–27.
https://doi.org/10.1159/000527284
Published Online: 14 March 2023
View articletitled, Clonal Megakaryocyte Dysplasia with Isolated Thrombocytosis Is a Distinct Myeloproliferative Neoplasm Phenotype
Open the PDF for Clonal Megakaryocyte Dysplasia with Isolated Thrombocytosis Is a Distinct Myeloproliferative Neoplasm Phenotype in another window
Journal Articles

High Incidences of Acute and Chronic Graft-Versus-Host Disease after Hematopoietic Cell Transplants for Acute Myeloid Leukemia Using Thiotepa, Busulfan, and Fludarabine Pretransplant Conditioning

Subject Area:
Karger e-Journal Backfile Collection 2023 , Hematology , Oncology
Khalid Abdelrahman Halahleh, Mohammad Ma’koseh, Iyad Sultan, Dalia Hussein Rimawi, Isra Muradi, Robert Peter Gale
Journal: Acta Haematologica
Acta Haematol (2023) 146 (1): 91–94.
https://doi.org/10.1159/000528306
Published Online: 14 March 2023
View articletitled, High Incidences of Acute and Chronic Graft-Versus-Host Disease after Hematopoietic Cell Transplants for Acute Myeloid Leukemia Using Thiotepa, Busulfan, and Fludarabine Pretransplant Conditioning
Open the PDF for High Incidences of Acute and Chronic Graft-Versus-Host Disease after Hematopoietic Cell Transplants for Acute Myeloid Leukemia Using Thiotepa, Busulfan, and Fludarabine Pretransplant Conditioning in another window
Journal Articles

Ibrutinib in Advanced Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Lower Risk of Hepatitis B Virus Reactivation

Subject Area:
Hematology , Oncology
Shenmiao Yang, Rong Zhu, Nan Li, Yu Feng, Rui Zuo, Robert Peter Gale, Xiaojun Huang
Journal: Acta Haematologica
Acta Haematol (2022) 145 (1): 54–62.
https://doi.org/10.1159/000518398
Published Online: 20 September 2021
View articletitled, Ibrutinib in Advanced Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Lower Risk of Hepatitis B Virus Reactivation
Open the PDF for Ibrutinib in Advanced Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Lower Risk of Hepatitis B Virus Reactivation in another window
Journal Articles

Clonal Megakaryocyte Dysplasia with Normal Blood Values Is a Distinct Myeloproliferative Neoplasm

Subject Area:
Hematology , Oncology
Giovanni Barosi, Vittorio Rosti, Margherita Massa, Rita Campanelli, Laura Villani, Paolo Catarsi, Adriana Carolei, Carlotta Abbà, Corrado Lodigiani, Massimo Primignani, Giuliana Gregato, Francesco Bertolini, Umberto Magrini, Robert Peter Gale
Journal: Acta Haematologica
Acta Haematol (2022) 145 (1): 30–37.
https://doi.org/10.1159/000517207
Published Online: 19 July 2021
View articletitled, Clonal Megakaryocyte Dysplasia with Normal Blood Values Is a Distinct Myeloproliferative Neoplasm
Open the PDF for Clonal Megakaryocyte Dysplasia with Normal Blood Values Is a Distinct Myeloproliferative Neoplasm in another window
Journal Articles

How Do We Manage Hematopoietic Cell Transplant during the SARS-CoV-2 Pandemic?

Subject Area:
Topic Article Package: Coronavirus (COVID-19) , Hematology , Oncology
Haowen Xiao, Yi Luo, Jimin Shi, Aiyun Jin, Mohamad Mohty, Arnon Nagler, Robert Peter Gale, He Huang
Journal: Acta Haematologica
Acta Haematol (2021) 144 (5): 500–507.
https://doi.org/10.1159/000513036
Published Online: 09 March 2021
View articletitled, How Do We Manage Hematopoietic Cell Transplant during the SARS-CoV-2 Pandemic?
Open the PDF for How Do We Manage Hematopoietic Cell Transplant during the SARS-CoV-2 Pandemic? in another window
Journal Articles

Deoxycytidine Kinase ( DCK ) Mutations in Human Acute Myeloid Leukemia Resistant to Cytarabine

Subject Area:
Hematology , Oncology
Biao Wu, Zhengwei Jenny Mao, Zhi Wang, Pin Wu, Hongyu Huang, Wenjun Zhao, Lei Zhang, Zhou Zhang, Hongchao Yin, Robert Peter Gale, Bin Yin
Journal: Acta Haematologica
Acta Haematol (2021) 144 (5): 534–541.
https://doi.org/10.1159/000513696
Published Online: 24 February 2021
View articletitled, Deoxycytidine Kinase ( DCK ) Mutations in Human Acute Myeloid Leukemia Resistant to Cytarabine
Open the PDF for Deoxycytidine Kinase ( DCK ) Mutations in Human Acute Myeloid Leukemia Resistant to Cytarabine in another window
Journal Articles

Is G-CSF Dangerous in COVID-19: Why Not Use GM-CSF?

Subject Area:
Topic Article Package: Coronavirus (COVID-19) , Hematology , Oncology
Hillard M. Lazarus, Robert Peter Gale
Journal: Acta Haematologica
Acta Haematol (2021) 144 (3): 350–351.
https://doi.org/10.1159/000512574
Published Online: 06 November 2020
View articletitled, Is G-CSF Dangerous in COVID-19: Why Not Use GM-CSF?
Open the PDF for Is G-CSF Dangerous in COVID-19: Why Not Use GM-CSF? in another window
Journal Articles

A Haematologist’s Guide to Coronavirus Disease 2019: Encyclopaedia or Doorstop?

Subject Area:
Hematology , Oncology
Robert Peter Gale
Journal: Acta Haematologica
Acta Haematol (2021) 144 (1): 8–9.
https://doi.org/10.1159/000510498
Published Online: 08 October 2020
View articletitled, A Haematologist’s Guide to Coronavirus Disease 2019: Encyclopaedia or Doorstop?
Open the PDF for A Haematologist’s Guide to Coronavirus Disease 2019: Encyclopaedia or Doorstop? in another window
Journal Articles

G-CSF and GM-CSF Are Different. Which One Is Better for COVID-19?

Subject Area:
Topic Article Package: Coronavirus (COVID-19) , Hematology , Oncology
Hillard M. Lazarus, Robert Peter Gale
Journal: Acta Haematologica
Acta Haematol (2021) 144 (4): 355–359.
https://doi.org/10.1159/000510352
Published Online: 13 August 2020
View articletitled, G-CSF and GM-CSF Are Different. Which One Is Better for COVID-19?
Open the PDF for G-CSF and GM-CSF Are Different. Which One Is Better for COVID-19? in another window
Journal Articles

Perspective: SARS-CoV-2, COVID-19 and Haematologists

Subject Area:
Topic Article Package: Coronavirus (COVID-19) , Hematology , Oncology
Robert Peter Gale
Journal: Acta Haematologica
Acta Haematol (2021) 144 (2): 117–121.
https://doi.org/10.1159/000508021
Published Online: 06 May 2020
View articletitled, Perspective: SARS-CoV-2, COVID-19 and Haematologists
Open the PDF for Perspective: SARS-CoV-2, COVID-19 and Haematologists in another window
Journal Articles

Treating Plasma Cell Myeloma in Developing Countries: Does Everyone Need the Newest Drugs?

Subject Area:
Hematology , Oncology
Robert Peter Gale
Journal: Acta Haematologica
Acta Haematol (2020) 143 (6): 513–515.
https://doi.org/10.1159/000505991
Published Online: 10 March 2020
View articletitled, Treating Plasma Cell Myeloma in Developing Countries: Does Everyone Need the Newest Drugs?
Open the PDF for Treating Plasma Cell Myeloma in Developing Countries: Does Everyone Need the Newest Drugs? in another window
Journal Articles

Therapy for Immunoglobulin D Plasma Cell Myeloma

Subject Area:
Hematology , Oncology
Robert Peter Gale
Journal: Acta Haematologica
Acta Haematol (2018) 139 (3): 193–194.
https://doi.org/10.1159/000487043
Published Online: 11 April 2018
View articletitled, Therapy for Immunoglobulin D Plasma Cell Myeloma
Open the PDF for Therapy for Immunoglobulin D Plasma Cell Myeloma in another window
Journal Articles

Is Having Clonal Cytogenetic Abnormalities the Same as Having Leukaemia?

Subject Area:
Hematology , Oncology
Mirko Farina, Giuseppe Rossi, Daniella Bellotti, Eleonora Marchina, Robert Peter Gale
Journal: Acta Haematologica
Acta Haematol (2015) 135 (1): 39–42.
https://doi.org/10.1159/000437202
Published Online: 17 September 2015
View articletitled, Is Having Clonal Cytogenetic Abnormalities the Same as Having Leukaemia?
Open the PDF for Is Having Clonal Cytogenetic Abnormalities the Same as Having Leukaemia? in another window
Journal Articles

Isochromosome X in Myelodysplastic Syndrome

Subject Area:
Hematology , Oncology
Khalid Halahleh, Robert Peter Gale, Arnon Nagler
Journal: Acta Haematologica
Acta Haematol (2015) 135 (1): 37–38.
https://doi.org/10.1159/000435829
Published Online: 22 August 2015
View articletitled, Isochromosome X in Myelodysplastic Syndrome
Open the PDF for Isochromosome X in Myelodysplastic Syndrome in another window
Journal Articles

Treating Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors

Subject Area:
Hematology , Oncology
Robert Peter Gale, John M. Goldman
Journal: Acta Haematologica
Acta Haematol (2013) 130 (3): 192–195.
https://doi.org/10.1159/000351957
Published Online: 13 June 2013
View articletitled, Treating Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors
Open the PDF for Treating Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors in another window
Journal Articles

Serum Ferritin Is an Independent Prognostic Factor in Chinese with Myelodysplastic Syndromes Classified as IPSS Intermediate-1

Subject Area:
Hematology , Oncology
Bing Li, Zefeng Xu, Robert Peter Gale, Tiejun Qin, Yue Zhang, Zhijian Xiao
Journal: Acta Haematologica
Acta Haematol (2013) 129 (4): 243–250.
https://doi.org/10.1159/000345428
Published Online: 15 January 2013
View articletitled, Serum Ferritin Is an Independent Prognostic Factor in Chinese with Myelodysplastic Syndromes Classified as IPSS Intermediate-1
Open the PDF for Serum Ferritin Is an Independent Prognostic Factor in Chinese with Myelodysplastic Syndromes Classified as IPSS Intermediate-1 in another window
Journal Articles

How Helpful Are Meta-Analyses in Determining the Best Therapy of Blood Diseases?

Subject Area:
Hematology , Oncology
Robert Peter Gale, Hillard M. Lazarus
Journal: Acta Haematologica
Acta Haematol (2010) 125 (1-2): 91–101.
https://doi.org/10.1159/000318876
Published Online: 08 December 2010
View articletitled, How Helpful Are Meta-Analyses in Determining the Best Therapy of Blood Diseases?
Open the PDF for How Helpful Are Meta-Analyses in Determining the Best Therapy of Blood Diseases? in another window
Journal Articles

Oncogenes in Human Leukemias

Subject Area:
Hematology , Oncology
Anna Butturini, Emma Sthivelman, Eli Canaani, Robert Peter Gale
Journal: Acta Haematologica
Acta Haematol (1987) 78 (Suppl. 1): 2–10.
https://doi.org/10.1159/000205895
Published Online: 25 February 2009
View articletitled, Oncogenes in Human Leukemias
Open the PDF for Oncogenes in Human Leukemias in another window
Journal Articles

Analysis of BCR/ABL Abnormalities in mRNA from 20-Year-Old Paraffin-Embedded Tissue for BCR/ABL Rearrangement by Polymerase Chain Reaction

Subject Area:
Hematology , Oncology
Igor Aurer, Tohru Juhbashi, Ichiro Sekine, Masao Tomonaga, Robert Peter Gale
Journal: Acta Haematologica
Acta Haematol (1993) 90 (1): 5–7.
https://doi.org/10.1159/000204364
Published Online: 18 February 2009
View articletitled, Analysis of BCR/ABL Abnormalities in mRNA from 20-Year-Old Paraffin-Embedded Tissue for BCR/ABL Rearrangement by Polymerase Chain Reaction
Open the PDF for Analysis of BCR/ABL Abnormalities in mRNA from 20-Year-Old Paraffin-Embedded Tissue for BCR/ABL Rearrangement by Polymerase Chain Reaction in another window
Journal Articles

High Incidence of Conservative RAS Mutations in Acute Myeloid Leukemia

Subject Area:
Hematology , Oncology
Igor Aurer, Boris Labar, Damir Nemet, Radmila Ajduković, Vinko Bogdanić, Robert Peter Gale
Journal: Acta Haematologica
Acta Haematol (1994) 92 (3): 123–125.
https://doi.org/10.1159/000204200
Published Online: 18 February 2009
View articletitled, High Incidence of Conservative RAS Mutations in Acute Myeloid Leukemia
Open the PDF for High Incidence of Conservative RAS Mutations in Acute Myeloid Leukemia in another window